These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2524549)

  • 1. Comparison of the immunogenicity of reduced doses of two recombinant DNA hepatitis B vaccines in New Zealand children.
    Milne A; Brawner TA; Dumbill PC; Kawachi I; Pearce NE
    J Med Virol; 1989 Mar; 27(3):264-7. PubMed ID: 2524549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of low doses of recombinant hepatitis B vaccine in young males.
    Tsakalakis C; Richardson SC; Roumeliotou-Karayannis A; Papaevangelou G
    Vaccine; 1988 Aug; 6(4):328-30. PubMed ID: 2973188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of low doses of hepatitis B vaccine in children: a study in 650 New Zealand children.
    Milne A; Dimitrakakis M; Allwood G; Lucas R; Moyes C; Pearce N
    J Med Virol; 1987 Dec; 23(4):401-5. PubMed ID: 3694181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A; Moyes CD; Dimitrakakis M
    N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines.
    Hammond GW; Parker J; Mimms L; Tate R; Sekla L; Minuk G
    Vaccine; 1991 Feb; 9(2):97-100. PubMed ID: 1829306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B in children in a high risk New Zealand community, and control using recombinant DNA vaccine.
    Milne A; Heydon JL; Hindle RC; Pearce NE
    N Z Med J; 1989 Apr; 102(866):182-4. PubMed ID: 2523525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another.
    Bush LM; Moonsammy GI; Boscia JA
    Vaccine; 1991 Nov; 9(11):807-9. PubMed ID: 1836921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine.
    Tan KL; Oon CJ; Goh KT; Wong LY; Chan SH
    Acta Paediatr Scand; 1990; 79(6-7):593-8. PubMed ID: 2143619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose vaccination against hepatitis B in children: one-year follow-up.
    Milne A; Dimitrakakis M; Campbell C; Lucas R; Allwood G; Goldwater P; Pearce N; Krugman S
    J Med Virol; 1987 Aug; 22(4):387-92. PubMed ID: 3305787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the hepatitis B recombinant DNA yeast vaccine (H-B-VAX II) in children: two doses vs. three doses of 5 micrograms regime; an interim report.
    Lai CL; Yeoh EK; Chang WK; Lo VW; Ng LN
    J Infect; 1986 Jul; 13 Suppl A():19-25. PubMed ID: 2943812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose hepatitis B vaccination in children.
    Milne A; Allwood GK; Pearce NE; Lucas CR; Krugman S
    N Z Med J; 1986 Feb; 99(795):47-9. PubMed ID: 2935755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccination in children: five year booster study.
    Milne A; Krugman S; Waldon JA; Hadler SC; Lucas CR; Moyes CD; Pearce NE
    N Z Med J; 1992 Aug; 105(940):336-8. PubMed ID: 1508451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination in chronic renal failure patients undergoing haemodialysis: the immunogenicity of an increased dose of a recombinant DNA hepatitis B vaccine.
    Guan R; Tay HH; Choong HL; Yap I; Woo KT
    Ann Acad Med Singap; 1990 Nov; 19(6):793-7. PubMed ID: 2151841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of recombinant hepatitis B vaccine in dialysis patients.
    Jilg W; Schmidt M; Weinel B; Küttler T; Brass H; Bommer J; Müller R; Schulte B; Schwarzbeck A; Deinhardt F
    J Hepatol; 1986; 3(2):190-5. PubMed ID: 3794300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children.
    Hayashi J; Kashiwagi S; Kajiyama W; Ikematsu H; Noguchi A; Nomura H; Ikeda K
    J Infect; 1988 Jul; 17(1):49-55. PubMed ID: 2974467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.